文献速递神经免疫

视神经炎的诊断与分类

Diagnosis and classification of optic neuritis.
PubMed 文献 · Lancet Neurol · 2022-09-27

本文指出视神经炎尚无共识分类和精确诊断标准,导致以视神经炎为首发表现的疾病诊断困难。作者基于临床特征制定可能的视神经炎诊断标准,结合脑、眶、视网膜影像及抗体等生物标志物可确诊,并提出了视神经炎亚组分类。该标准可能减少误诊,并为治疗试验设计提供疾病病程信息。

要点

  • 视神经炎诊断需先基于临床特征判断为可能的视神经炎,再结合影像和抗体等辅助检查确诊。
  • 视神经炎病因常为非多发性硬化疾病,且因地理位置、治疗可及性和种族背景而异。
  • 作者制定的诊断标准与亚组分类可能降低误诊风险,并帮助判断长期药物治疗需求。

核心结论

  • 作者制定了视神经炎诊断标准及亚组分类,可能减少误诊风险,并为治疗试验设计和长期药物管理判断提供信息。

研究设计与样本

  • 本文为综述,未报告系统检索范围。

主要发现

  • 流行病学数据显示,累积来看视神经炎最常由多发性硬化以外的许多疾病引起。
  • 视神经炎的病因和管理在世界范围内因地理位置、治疗可及性和种族背景而异。

关键数值与推荐

  • 诊断标准基于临床特征可作出可能的视神经炎诊断。
  • 利用脑、眶和视网膜影像以及抗体和其他蛋白生物标志物等辅助检查可作出确诊的视神经炎诊断。
  • 辅助检查可回顾性应用于储存样本和历史脑或视网膜扫描,将有助于未来验证研究。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is no consensus regarding the classification of optic neuritis, and precise diagnostic criteria are not available. This reality means that the diagnosis of disorders that have optic neuritis as the first manifestation can be challenging. Accurate diagnosis of optic neuritis at presentation can facilitate the timely treatment of individuals with multiple sclerosis, neuromyelitis optica spectrum disorder, or myelin oligodendrocyte glycoprotein antibody-associated disease. Epidemiological data show that, cumulatively, optic neuritis is most frequently caused by many conditions other than multiple sclerosis. Worldwide, the cause and management of optic neuritis varies with geographical location, treatment availability, and ethnic background. We have developed diagnostic criteria for optic neuritis and a classification of optic neuritis subgroups. Our diagnostic criteria are based on clinical features that permit a diagnosis of possible optic neuritis; further paraclinical tests, utilising brain, orbital, and retinal imaging, together with antibody and other protein biomarker data, can lead to a diagnosis of definite optic neuritis. Paraclinical tests can also be applied retrospectively on stored samples and historical brain or retinal scans, which will be useful for future validation studies. Our criteria have the potential to reduce the risk of misdiagnosis, provide information on optic neuritis disease course that can guide future treatment trial design, and enable physicians to judge the likelihood of a need for long-term pharmacological management, which might differ according to optic neuritis subgroups.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Petzold A, Fraser CL, Abegg M, et al. Diagnosis and classification of optic neuritis. Lancet Neurol. 2022. PMID: 36179757. doi:10.1016/S1474-4422(22)00200-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。